[What are the possibilities for treatment of hyperlipidemia in kidney insufficiency or in dialysis patients?].
作者信息
Grützmacher P, Scheuermann E
出版信息
Med Welt. 1982 Jun 18;33(24):873-4.
PMID:7109928
Abstract
摘要
相似文献
1
[What are the possibilities for treatment of hyperlipidemia in kidney insufficiency or in dialysis patients?].[肾功能不全或透析患者中高脂血症的治疗有哪些可能性？]
Med Welt. 1982 Jun 18;33(24):873-4.
2
3
[Effects on simvastatin in continuous ambulatory peritoneal dialysis patients with hyperlipidemia].辛伐他汀对持续性非卧床腹膜透析高脂血症患者的影响
Hunan Yi Ke Da Xue Xue Bao. 2000 Apr 28;25(2):154-6.
4
[Causes and risks of hyperlipidemia during dialysis and after renal transplantation].
Recenti Prog Med. 1998 Nov;89(11):590-7.
5
[Therapeutic management].[治疗管理]
Nephrologie. 2000;21(7):383-92.
6
[Kidney diseases associated with hyperlipidemia and its treatment].[与高脂血症相关的肾脏疾病及其治疗]
Duodecim. 1991;107(16):1315-22.
7
[Clofibrate treatment of hyperlipidemia in long-term dialysis patients].[氯贝丁酯治疗长期透析患者高脂血症]
Med Welt. 1976 Nov 19;27(47):2278-9.
8
9
Treatment of hyperlipidemia in human renal disease.
Miner Electrolyte Metab. 1993;19(3):196-204.
10
K/DOQI gets to the heart of managing dyslipidemias in patients with CKD.美国肾脏病基金会慢性肾脏病临床实践指南抓住了慢性肾脏病患者血脂异常管理的核心。
Nephrol Nurs J. 2005 May-Jun;32(3):337-8.
Zotero 插件